Liposome bupivacaine (EXPAREL®) for extended pain relief in patients undergoing ileostomy reversal at a single institution with a fast-track discharge protocol: an IMPROVE Phase IV health economics trial
Authors:
- Sharon SalernoSSSharon Salerno
- Jon VogelJVJon Vogel
Open Access
- 1 July 2013
- journal article
- Published by Taylor & Francis in Journal of Pain Research
- Vol. 6, 605-610
Abstract
Peer reviewed article authored by (Vogel JD). Read article or submit your manuscript for publishing.Keywords
This publication has 22 references indexed in Scilit:
- Extended pain relief trial utilizing infiltration of Exparel®, a long-acting multivesicular liposome formulation of bupivacaine: a Phase IV health economic trial in adult patients undergoing open colectomyJournal of Pain Research, 2012
- Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesiaJournal of Pain Research, 2012
- Closure of loop ileostomy: potentially a daycase procedure?Techniques in Coloproctology, 2011
- Postoperative management after loop ileostomy closure: are we keeping patients in hospital too long?The Annals of The Royal College of Surgeons of England, 2010
- The morbidity surrounding reversal of defunctioning ileostomies: a systematic review of 48 studies including 6,107 casesInternational Journal of Colorectal Disease, 2009
- Complications of Loop Ileostomy Closure: A Retrospective Cohort Analysis of 123 PatientsWorld Journal of Surgery, 2008
- Morbidity of Ostomy TakedownJournal of Gastrointestinal Surgery, 2008
- Techniques and complications of ileostomy takedownThe American Journal of Surgery, 1999
- Same-day surgery ileostomy closure?1997
- COMPLICATIONS FOLLOWING CLOSURE OF LOOP ILEOSTOMYAnz Journal of Surgery, 1991